Barinthus Biotherapeutics
Vaccitech is a clinical stage biotech company utilising T cell mediated immune responses to treat and prevent infectious diseases and cancer. The company was a co-inventor of the Oxford/AstraZeneca Covid-19 vaccine and went public in May 2021.
- What
- Life Sciences
- When
- Mar 2016
- CEO
- Bill Enright
- Status
- Public
- Investment
- Active
- OSE Board Director
- Alex Hammacher